Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Epilepsy Res. 2017 Aug 24;137:139–144. doi: 10.1016/j.eplepsyres.2017.08.005

Fig. 1. ICV injection of atomoxetine reduces S-IRA in DBA/1 mice.

Fig. 1

A, ICV administration of atomoxetine at 200–250 nmol reduced S-IRA in primed DBA/1 mice 2h after microinjection. B, a representative example of histology showing that the vehicle or the chemical was successfully delivered into the ventricle.

** p < 0.01; *** p < 0.001: Significantly different from vehicle control.